Evidence map›Paper›PMID 29886423›Full record

Trial reportJournal of the American Heart Association2018

Upward Shift and Steepening of the Blood Pressure Response to Exercise in Hypertensive Subjects at High Altitude.

Sergio Caravita, Andrea Faini, Claudia Baratto, Grzegorz Bilo, Josè Luis Macarlupu, Morin Lang, Miriam Revera, Carolina Lombardi, Francisco C Villafuerte, Piergiuseppe Agostoni and 1 more

Registry-linked trialOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of the American Heart Association, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01830530 (HIGH Altitude CArdiovascular REsearch in the ANDES), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01830530 phase4completednot on this map

HIGH Altitude CArdiovascular REsearch in the ANDES

TypeinterventionalSponsorIstituto Auxologico ItalianoRan2012 to 2012Enrolled100ConditionsHypertension, High AltitudeArmsTelmisartan, Nifedipine, placebo
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 16 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 3 countries.

Sergio CaravitaDepartment of Cardiovascular, Neural and Metabolic Sciences, S. Luca Hospital IRCCS Istituto Auxologico Italiano, Milan, Italy.
Andrea FainiDepartment of Cardiovascular, Neural and Metabolic Sciences, S. Luca Hospital IRCCS Istituto Auxologico Italiano, Milan, Italy.
Claudia BarattoDepartment of Cardiovascular, Neural and Metabolic Sciences, S. Luca Hospital IRCCS Istituto Auxologico Italiano, Milan, Italy.
Grzegorz BiloDepartment of Cardiovascular, Neural and Metabolic Sciences, S. Luca Hospital IRCCS Istituto Auxologico Italiano, Milan, Italy.
Josè Luis MacarlupuLaboratorio de Fisiologia Comparada, Facultad de Ciencias y Filosofia, Universidad Peruana Cayetano Heredia, Lima, Peru.
Morin LangDepartment de Ciencias de la Rehabilitación y del Movimiento Humano, Universidad de Antofagasta, Chile.
Miriam ReveraDepartment of Cardiovascular, Neural and Metabolic Sciences, S. Luca Hospital IRCCS Istituto Auxologico Italiano, Milan, Italy.
Carolina LombardiDepartment of Cardiovascular, Neural and Metabolic Sciences, S. Luca Hospital IRCCS Istituto Auxologico Italiano, Milan, Italy.
Francisco C VillafuerteLaboratorio de Fisiologia Comparada, Facultad de Ciencias y Filosofia, Universidad Peruana Cayetano Heredia, Lima, Peru.
Piergiuseppe AgostoniCentro Cardiologico Monzino, IRCCS, Milan, Italy.
Gianfranco ParatiDepartment of Cardiovascular, Neural and Metabolic Sciences, S. Luca Hospital IRCCS Istituto Auxologico Italiano, Milan, Italy gianfranco.parati@unimib.it.
IRCCS Istituto Auxologico Italiano · ITUniversity of Milano-Bicocca · ITUniversidad Peruana Cayetano Heredia · PECentro Cardiologico Monzino · ITUniversity of Antofagasta · CL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAcute exposure to high-altitude hypobaric hypoxia induces a blood pressure rise in hypertensive humans, both at rest and during exercise. It is unclear whether this phenomenon reflects specific blood pressure hyperreactivity or rather an upward shift of blood pressure levels. We aimed at evaluating the extent and rate of blood pressure rise during exercise in hypertensive subjects acutely exposed to high altitude, and how these alterations can be counterbalanced by antihypertensive treatment. METHODS AND

resultsFifty-five subjects with mild hypertension, double-blindly randomized to placebo or to a fixed-dose combination of an angiotensin-receptor blocker (telmisartan 80 mg) and a calcium-channel blocker (nifedipine slow release 30 mg), performed a cardiopulmonary exercise test at sea level and after the first night's stay at 3260 m altitude. High-altitude exposure caused both an 8 mm Hg upward shift (

conclusionsIn hypertensive subjects exposed to high altitude, we observed a hypoxia-driven upward shift and steepening of the blood pressure response to exercise. The effect of the combination of telmisartan/nifedipine slow release outweighed these changes and was associated with better muscle oxygen delivery. CLINICAL

trial registrationURL: http://www.clinicaltrials.gov. Unique identifier: NCT01830530.

Indexed as

AltitudeExerciseAdultAngiotensin II Type 1 Receptor BlockersAntihypertensive AgentsBlood PressureCalcium Channel BlockersDouble-Blind MethodDrug CombinationsFemaleHumansHypertensionMaleMiddle AgedNifedipineTelmisartanAngiotensin II Type 1 Receptor BlockersAntihypertensive AgentsCalcium Channel BlockersDrug CombinationsNifedipineTelmisartanblood pressureexercise physiologyhigh altitudehypoxiaoxygen consumption

Identifiers

PMID29886423
PMCPMC6220550
OpenAlexW2806333807

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.